Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 178
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Does the Experience of Awe Predict Ketamine's Rapid Antidepressant Effect?

    Ketamine is a very rapidly-acting and safe antidepressant medication given as an intravenous infusion, during...

    Are Implanted Prosthetic Legs for Horses Possible?

    An unacceptable number of otherwise healthy horses are euthanized each year from lower limb ailments for which...

    Open Insulin

    A team of biohackers is developing the first open source protocol to produce insulin simply and economically...

    Backer Badge Funded